In today’s briefing:
- Macquarie’s £8.7/share Bid for Renewi Supported by Key Shareholders Amid 9% Spread and Due Diligence Completion
- What’s New(s) in Amsterdam – 13 December [IMCD | NX Filtration]
- INOD: Growth Pathway in 2025
Macquarie’s £8.7/share Bid for Renewi Supported by Key Shareholders Amid 9% Spread and Due Diligence Completion
- Macquarie Asset Management’s final bid for Renewi is £8.7/share, with a current spread of 9% and a downside risk of 25%.
- Three shareholders holding 15.1% of Renewi have signed irrevocable support agreements; confirmatory due diligence is ongoing.
- Macquarie’s offer values Renewi at 6.7x TTM adj. EBITDA, aligning with European peers’ valuations, considering the control premium.
What’s New(s) in Amsterdam – 13 December [IMCD | NX Filtration]
- In this edition: • IMCD | acquires Daoqin in China • NX Filtration | revises FY24 revenue outlook strongly downwards
INOD: Growth Pathway in 2025
- The risk to INOD experiencing a sequential decline in spending activity in the near-term could have been alleviated from the continued spending in artificial intelligence (“A.I.”).
- AMZN and GOOGL have their internally developed processors ready for high performance deep learning. The new chips suggest A.I. training is not going anywhere and could expand in 2025.
- INOD’s revenue growth has been predominantly from one customer. This should begin to change in 2025.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
